Canino, Fabio
Canino, Fabio
Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto
Adding weekly carboplatin to sequential anthracycline and paclitaxel-based chemotherapy as neoadjuvant treatment for triple negative breast cancer (TNBC) patients: a propensity scorematched study
2021 Dieci, M. V.; Carbognin, L.; Cumerlato, E.; Canino, F.; Griguolo, G.; Giorgi, C. A.; Amato, O.; Genovesi, E.; Garufi, G.; Giannarelli, D.; Tornincasa, A.; Trudu, L.; Michieletto, S.; Saibene, T.; Conte, P.; Piacentini, F.; Bria, E.; Guarneri, V.
Atezolizumab-Related Sarcoidosis-Like Reaction in Early Breast Cancer Patient: Know It To Diagnose It: A Case Report with Review of the Literature
2022 Tornincasa, Antonio; Canino, Fabio; Trudu, Lucia; Barbolini, Monica; Moscetti, Luca; Omarini, Claudia; Dominici, Massimo; Piacentini, Federico
Cemiplimab- and nivolumab-induced myasthenia gravis: two clinical cases
2021 Canino, F.; Pugliese, G.; Baldessari, C.; Greco, S.; Depenni, R.; Dominici, M.
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation (British Journal of Cancer, (2023), 128, 2, (266-274), 10.1038/s41416-022-02050-8)
2023 Dieci, M. V.; Carbognin, L.; Miglietta, F.; Canino, F.; Giorgi, C. A.; Cumerlato, E.; Amato, O.; Massa, D.; Griguolo, G.; Genovesi, E.; Garufi, G.; Giannarelli, D.; Tornincasa, A.; Trudu, L.; Michieletto, S.; Saibene, T.; Lo Mele, M.; Fassan, M.; Zarrilli, G.; Piacentini, F.; Bria, E.; Guarneri, V.
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation
2023 Dieci, M. V.; Carbognin, L.; Miglietta, F.; Canino, F.; Giorgi, C. A.; Cumerlato, E.; Amato, O.; Massa, D.; Griguolo, G.; Genovesi, E.; Garufi, G.; Giannarelli, D.; Tornincasa, A.; Trudu, L.; Michieletto, S.; Saibene, T.; Lo Mele, M.; Fassan, M.; Zarrilli, G.; Piacentini, F.; Bria, E.; Guarneri, V.
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer
2021 Barbolini, M.; Omarini, C.; Moscetti, L.; Canino, F.; Trudu, L.; Tornincasa, A.; Caggia, F.; Bettelli, S.; Manfredini, S.; Isca, C.; Molinaro, A.; Dominici, M.; Piacentini, F.
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients
2024 Canino, F; Tornincasa, A; Bettelli, S; Manfredini, S; Barbolini, M; Moscetti, L; Omarini, C; Toss, A; Tamburrano, F; Antonelli, G; Baglio, F; Belluzzi, L; Martinelli, G; Natalizio, S; Ponzoni, O; Dominici, M; Piacentini, F.
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review.
2022 Canino, F; Piacentini, F; Omarini, C; Toss, A; Barbolini, M; Vici, P; Dominici, M; Moscetti, L.
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis.
2022 Omarini, C; Piacentini, F; Sperduti, I; Cerma, K; Barbolini, M; Canino, F; Nasso, C; Isca, C; Caggia, F; Dominici, M; Moscetti, L.
Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges
2023 Cerma, K.; Piacentini, F.; Moscetti, L.; Barbolini, M.; Canino, F.; Tornincasa, A.; Caggia, F.; Cerri, S.; Molinaro, A.; Dominici, M.; Omarini, C.
TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis
2021 Omarini, Claudia; Piacentini, Federico; Sperduti, Isabella; Cerma, Krisida; Barbolini, Monica; Canino, Fabio; Nasso, Cecilia; Dominici, Massimo; Moscetti, Luca
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis
2021 Omarini, C.; Piacentini, F.; Sperduti, I.; Cerma, K.; Barbolini, M.; Canino, F.; Nasso, C.; Isca, C.; Caggia, F.; Dominici, M.; Moscetti, L.
The Prognostic Role of Early Skeletal Muscle Mass Depletion in Multimodality Management of Patients with Advanced Gastric Cancer Treated with First Line Chemotherapy: A Pilot Experience from Modena Cancer Center
2021 Rimini, M; Pecchi, A; Prampolini, F; Bussei, C; Salati, M; Forni, D; Martelli, F; Valoriani, F; Canino, F; Bocconi, A; Gelsomino, F; Reverberi, L; Benatti, S; Piacentini, F; Menozzi, R; Dominici, M; Luppi, G; Spallanzani, A
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis
2021 Moscetti, Luca; Omarini, Claudia; Sperduti, Isabella; Canino, Fabio; Barbolini, Monica; Nasso, Cecilia; Toss, Angela; Dominici, Massimo; Piacentini, Federico
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis
2023 D'Onofrio, R.; Sperduti, I.; Piacentini, F.; Barbolini, M.; Omarini, C.; Toss, A.; Cortesi, L.; Barbieri, E.; Canino, F.; Dominici, M.; Moscetti, L.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Adding weekly carboplatin to sequential anthracycline and paclitaxel-based chemotherapy as neoadjuvant treatment for triple negative breast cancer (TNBC) patients: a propensity scorematched study | 1-gen-2021 | Dieci, M. V.; Carbognin, L.; Cumerlato, E.; Canino, F.; Griguolo, G.; Giorgi, C. A.; Amato, O.; Genovesi, E.; Garufi, G.; Giannarelli, D.; Tornincasa, A.; Trudu, L.; Michieletto, S.; Saibene, T.; Conte, P.; Piacentini, F.; Bria, E.; Guarneri, V. | |
Atezolizumab-Related Sarcoidosis-Like Reaction in Early Breast Cancer Patient: Know It To Diagnose It: A Case Report with Review of the Literature | 1-gen-2022 | Tornincasa, Antonio; Canino, Fabio; Trudu, Lucia; Barbolini, Monica; Moscetti, Luca; Omarini, Claudia; Dominici, Massimo; Piacentini, Federico | |
Cemiplimab- and nivolumab-induced myasthenia gravis: two clinical cases | 1-gen-2021 | Canino, F.; Pugliese, G.; Baldessari, C.; Greco, S.; Depenni, R.; Dominici, M. | |
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation (British Journal of Cancer, (2023), 128, 2, (266-274), 10.1038/s41416-022-02050-8) | 1-gen-2023 | Dieci, M. V.; Carbognin, L.; Miglietta, F.; Canino, F.; Giorgi, C. A.; Cumerlato, E.; Amato, O.; Massa, D.; Griguolo, G.; Genovesi, E.; Garufi, G.; Giannarelli, D.; Tornincasa, A.; Trudu, L.; Michieletto, S.; Saibene, T.; Lo Mele, M.; Fassan, M.; Zarrilli, G.; Piacentini, F.; Bria, E.; Guarneri, V. | |
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluation | 1-gen-2023 | Dieci, M. V.; Carbognin, L.; Miglietta, F.; Canino, F.; Giorgi, C. A.; Cumerlato, E.; Amato, O.; Massa, D.; Griguolo, G.; Genovesi, E.; Garufi, G.; Giannarelli, D.; Tornincasa, A.; Trudu, L.; Michieletto, S.; Saibene, T.; Lo Mele, M.; Fassan, M.; Zarrilli, G.; Piacentini, F.; Bria, E.; Guarneri, V. | |
Next Generation Sequencing (NGS): a possible game changer in metastatic breast cancer | 1-gen-2021 | Barbolini, M.; Omarini, C.; Moscetti, L.; Canino, F.; Trudu, L.; Tornincasa, A.; Caggia, F.; Bettelli, S.; Manfredini, S.; Isca, C.; Molinaro, A.; Dominici, M.; Piacentini, F. | |
Real-World Data and Clinical Implications of Next-Generation Sequencing (NGS)-Based Analysis in Metastatic Breast Cancer Patients | 1-gen-2024 | Canino, F; Tornincasa, A; Bettelli, S; Manfredini, S; Barbolini, M; Moscetti, L; Omarini, C; Toss, A; Tamburrano, F; Antonelli, G; Baglio, F; Belluzzi, L; Martinelli, G; Natalizio, S; Ponzoni, O; Dominici, M; Piacentini, F. | |
Role of Intrinsic Subtype Analysis with PAM50 in Hormone Receptors Positive HER2 Negative Metastatic Breast Cancer: A Systematic Review. | 1-gen-2022 | Canino, F; Piacentini, F; Omarini, C; Toss, A; Barbolini, M; Vici, P; Dominici, M; Moscetti, L. | |
T-DM1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis. | 1-gen-2022 | Omarini, C; Piacentini, F; Sperduti, I; Cerma, K; Barbolini, M; Canino, F; Nasso, C; Isca, C; Caggia, F; Dominici, M; Moscetti, L. | |
Targeting PI3K/AKT/mTOR Pathway in Breast Cancer: From Biology to Clinical Challenges | 1-gen-2023 | Cerma, K.; Piacentini, F.; Moscetti, L.; Barbolini, M.; Canino, F.; Tornincasa, A.; Caggia, F.; Cerri, S.; Molinaro, A.; Dominici, M.; Omarini, C. | |
TDM-1 efficacy in trastuzumab-pertuzumab pre-treated HER2 positive metastatic breast cancer patients: A meta-analysis | 1-gen-2021 | Omarini, Claudia; Piacentini, Federico; Sperduti, Isabella; Cerma, Krisida; Barbolini, Monica; Canino, Fabio; Nasso, Cecilia; Dominici, Massimo; Moscetti, Luca | |
TDM-1 efficacy in trastuzumabpertuzumab pre-treated HER2 positive metastatic breast cancer patients: a meta-analysis | 1-gen-2021 | Omarini, C.; Piacentini, F.; Sperduti, I.; Cerma, K.; Barbolini, M.; Canino, F.; Nasso, C.; Isca, C.; Caggia, F.; Dominici, M.; Moscetti, L. | |
The Prognostic Role of Early Skeletal Muscle Mass Depletion in Multimodality Management of Patients with Advanced Gastric Cancer Treated with First Line Chemotherapy: A Pilot Experience from Modena Cancer Center | 1-gen-2021 | Rimini, M; Pecchi, A; Prampolini, F; Bussei, C; Salati, M; Forni, D; Martelli, F; Valoriani, F; Canino, F; Bocconi, A; Gelsomino, F; Reverberi, L; Benatti, S; Piacentini, F; Menozzi, R; Dominici, M; Luppi, G; Spallanzani, A | |
Thromboembolism (TE) and adjuvant endocrine therapy (AET) in hormone receptor positive (HR+) early breast cancer (EBC): Did the evolution of treatment change the incidence of the adverse event? A metanalysis | 1-gen-2021 | Moscetti, Luca; Omarini, Claudia; Sperduti, Isabella; Canino, Fabio; Barbolini, Monica; Nasso, Cecilia; Toss, Angela; Dominici, Massimo; Piacentini, Federico | |
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-Analysis | 1-gen-2023 | D'Onofrio, R.; Sperduti, I.; Piacentini, F.; Barbolini, M.; Omarini, C.; Toss, A.; Cortesi, L.; Barbieri, E.; Canino, F.; Dominici, M.; Moscetti, L. |